24 December 2019 - - US-based synthetic genomics technologies and DNA data storage specialist SGI-DNA, Inc has appointed Brian Donnelly to the newly created position of chief commercial officer, the company said.

Donnelly is a seasoned commercial and operational leader with expertise in developing markets and launching disruptive technologies in the genomics industry and will be responsible for Global Sales, Marketing, Customer Service and Support, and Business Development.

Donnelly joins from Illumina where he most recently led Illumina's global service organization with general management responsibility and leadership oversight for a 900-person commercial team.

During his time at Illumina, Donnelly also led the Global Commercial Strategy and Global Clinical Marketing teams during numerous product launches.

Before Illumina, Donnelly led Global Marketing and Commercial Operations at Sequenom where he was responsible for all aspects of business strategy, product management, marketing, communications and field operations.

He has also held commercial and operational leadership roles in the pharmaceutical and device space at GlaxoSmithKline and Allergan, with a specific focus on the vaccines and oncology markets. Brian received a BS in Business Administration from Elon University, and both an MBA and a JD from Rutgers University.

At SGI-DNA, our mission is to develop revolutionary synthetic genomics platforms that accelerate advances in drug discovery, precision medicine, DNA data storage, and industrial design; bridging the gap between the digital and biological worlds.